Hydroxyzinum Vp

Hydroxyzine hydrochloride, the active ingredient in Hydroxyzinum Vp, is an antihistamine presented as an oral dosage form for systemic use. It is employed to relieve allergic skin reactions, reduce pruritus, provide anxiolytic effects, aid pre‑operative sedation, and control nausea and vomiting in adult patients.

GNH USA supplies Hydroxyzinum Vp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union regulatory requirements and is manufactured under GMP conditions. It is distributed through GNH USA's global logistics network to ensure timely delivery.

Hydroxyzine hydrochloride is an H1‑antihistamine used to manage conditions related to allergic and anxiety pathways.

- Allergic skin reactions: reduces histamine‑mediated itching and inflammation. - Pruritus: provides relief from chronic itching associated with dermatologic disorders. - Anxiety: produces calming effects useful in short‑term management of anxiety. - Pre‑operative sedation: facilitates anxiolysis and sedation before surgical procedures. - Nausea and vomiting: helps control postoperative or medication‑induced emesis.

Hydroxyzine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to a sticky sensation. - Blurred vision: temporary difficulty focusing. - Constipation: reduced bowel motility.

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythms, especially in predisposed patients. - Severe hypotension: marked drop in blood pressure that may cause dizziness. - Anaphylactic reactions: sudden, life‑threatening allergic response.

When prescribing hydroxyzine, clinicians should consider several safety measures.

- Assess hepatic function: adjust use in patients with liver impairment. - Use caution in the elderly: increased sensitivity to sedative effects. - Avoid concurrent CNS depressants: risk of additive sedation and respiratory depression. - Monitor for QT prolongation: especially when combined with other QT‑affecting agents. - Do not use in patients with known hypersensitivity to hydroxyzine or related compounds. - Store at ambient temperature: keep in the original pack, protect from moisture.

Hydroxyzine can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause severe hypotension. - CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression. - Anticholinergic drugs: increased anticholinergic burden leading to confusion or urinary retention.

Moderate Interactions (Monitor Closely): - Alcohol: enhances drowsiness and impairment. - Other antihistamines: may increase overall sedation. - QT‑prolonging agents: monitor ECG for potential arrhythmia.